Oral Drug Slows Stargardt Disease Progression in Phase 2 Clinical Trial
Tuesday, March 5 2024 | 08 h 05 min | Vision Science
Results from a Phase 2 clinical trial show that an oral drug, Tinlarebant, may slow progression of Stargardt disease Belite Bio, a...
Read More
Dynamic & Comprehensive VisionEd Conference Program Announced for VEE 2024
Monday, March 4 2024 | 15 h 54 min | News
The Vision Council and RX, co-organizers of Vision Expo, bring compelling accredited continuing education offerings to the industry at Vision Expo...
Read More
Balancing Style and Functionality in Frame Selection
Monday, March 4 2024 | 09 h 54 min | Fashion Frames
By Tina Guenther From the moment a patient steps into the dispensary, they are met with a unique prescription and a set of preferences Often,...
Read More
Optometry Giving Sight’s Grant Process Now Open
Monday, March 4 2024 | 09 h 23 min | News
Optometry Giving Sight (OGS) is now accepting pre-applications for its grant program that funds sustainable, optometry-based projects to end...
Read More
VEE 2024 Unveils New Main Stage Special Events
Monday, March 4 2024 | 09 h 00 min | News
The Vision Council and RX, co-organizers of Vision Expo, have shared the line-up of events scheduled to take place at The Bridge, Vision Expo...
Read More
